Conjugated equine estrogen

Phase 2Small molecule

SSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conjugated equine estrogen is one of 59 small molecule programs targeting Arthralgia. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ArthralgiaActive, not recruiting

Hot FlashesActive, not recruiting

ArthralgiaPhase 2

Active, not recruiting

Hot FlashesPreclinical

Active, not recruiting

Competition

Competitive Landscape

55 competitors in Hot Flashes

#DrugCompanyPhaseTrials

Lupron

AbbVie

Approved

1 2

Nolvadex

AstraZeneca

Approved

1 3

Veozah

Astellas

Phase 3

13 4

Ambien

PPurdue Pharma LP

Approved

1 5

Orserdu

SStemline Therapeutics, Inc.

Approved

—6

Nitrostat

VViatris Specialty LLC

Depo-Provera

1 8

Depo-Provera

Eli Lilly

Phase 3

1 9

Neurontin

VViatris Specialty LLC

Phase 3

7 10

Megace

Bristol-Myers Squibb

Phase 3

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hot flashes1 trial

Study of PET Scans and Serotonin in Hot Flashes Treatment

Terminated·SSidney Kimmel Comprehensive Cancer Center at Johns Hopkins·N/A·NCT00249847·5 enrolled

Arthralgia1 trial

Effects of Hormone Replacement Therapy on Arthralgia in Postmenopausal Women

Unknown status·HHospital de Clinicas de Porto Alegre·Phase 2·NCT02838576·72 enrolled

Trial1 trial

Vaginal and Urinary Microbiome Trial

Completed·UUniversity of Louisville·Phase 4·NCT02869165·110 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Conjugated equine estrogen. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Conjugated equine estrogen compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Conjugated equine estrogen. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: SSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conjugated equine estrogen

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Hot flashes1 trial

Arthralgia1 trial

Trial1 trial

References

Drug Info

Quick Facts

Related News